ESR1 and cancer: Insufficient BRCA1 (haploinsufficiency) impairs DDR and reduces the ability to repress estrogen receptor (ER-α) signaling, thus inducing genetic mutations and leading to cancer in mammary and ovarian epithelial cells [54].